Insider Trading March 9, 2026

Stilwell Affiliates Add 2,657 Shares to Stakes in Peoples Financial (PFBX)

Collective buy of roughly $55,800 comes as shares trade close to their 52-week peak and InvestingPro flags the stock as overvalued

By Sofia Navarro PFBX
Stilwell Affiliates Add 2,657 Shares to Stakes in Peoples Financial (PFBX)
PFBX

A group of Stilwell-affiliated investment vehicles and Joseph Stilwell purchased 2,657 shares of Peoples Financial Corp (NASDAQ: PFBX) on March 6, 2026, at $21.00 per share, a transaction valued at about $55,797. The purchase occurs as the stock trades near its 52-week high and after InvestingPro analysis classified the share price as overvalued relative to its Fair Value estimate.

Key Points

  • A group of Stilwell-affiliated entities and Joseph Stilwell, all 10% owners of Peoples Financial Corp (PFBX), collectively purchased 2,657 shares on March 6, 2026 at $21.00 per share, totaling about $55,797.
  • Post-transaction direct holdings reported: Stilwell Activist Investments, L.P. - 464,870 shares; Stilwell Activist Fund, L.P. - 67,505 shares; Stilwell Value Partners VII, L.P. - 205,760 shares. Joseph Stilwell indirectly owns these shares.
  • PFBX was trading at $21.11, near a 52-week high of $22.54, with a one-year return of 11.67%; company metrics noted include a $97.5 million valuation, a P/E of 20.57 and a 1.71% dividend yield. InvestingPro flags the stock as overvalued relative to its Fair Value estimate and highlights profitability and a nine-year dividend payment streak.

A consortium of Stilwell-related entities - Stilwell Value LLC, Stilwell Value Partners VII, L.P., Stilwell Activist Fund, L.P., Stilwell Activist Investments, L.P. - together with Joseph Stilwell, all identified as 10% owners of Peoples Financial Corp (NASDAQ: PFBX), bought 2,657 shares of the bank's common stock on March 6, 2026.

The shares were acquired at $21.00 apiece, producing a combined purchase amount of approximately $55,797. The transaction followed existing holdings by the Stilwell-affiliated vehicles: Stilwell Activist Investments, L.P. now directly holds 464,870 shares; Stilwell Activist Fund, L.P. directly owns 67,505 shares; and Stilwell Value Partners VII, L.P. directly holds 205,760 shares. The reporting notes that Joseph Stilwell indirectly owns these positions.

At the time of the disclosure, PFBX was trading at $21.11, close to its 52-week high of $22.54. Over the prior 12 months the stock returned 11.67% for investors. The company carries a market valuation of $97.5 million, a price-to-earnings ratio of 20.57 and distributes a dividend with a 1.71% yield. Analysis from InvestingPro included in the disclosure indicates that PFBX appears overvalued when compared with its Fair Value estimate, ranking it among companies classified as most overvalued. InvestingPro also highlights the firm's profitability measures and notes a nine-year streak of dividend payments.


These holdings and the recent small-scale purchase reflect incremental insider buying by a closely affiliated group of significant shareholders. The reported changes in direct ownership quantify the footprint of the Stilwell vehicles on PFBX's shareholder register.

Given the size of the company and the particulars of the share metrics reported, investors and market observers may reference the disclosed ownership figures, recent price action and InvestingPro's valuation assessment when evaluating PFBX's current positioning in the market.

Risks

  • Valuation risk - InvestingPro analysis identifies PFBX as overvalued relative to its Fair Value estimate, potentially constraining upside for new investors (impacts equity valuation considerations).
  • Price-level uncertainty - the stock is trading close to its 52-week high, which could indicate limited near-term price appreciation from current levels (impacts short-term equity performance).
  • Market-cap related uncertainty - with a company valuation reported at $97.5 million, investors should note the smaller market capitalization when assessing liquidity and volatility profiles (impacts investor risk assessments in the financials sector).

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026